ICHR · Ichor Holdings

Current Thesis

The WFE-recovery thesis that sat DORMANT in late April has fired in full and is now mid-correction. Ichor a fluid/gas/chemical delivery subsystem supplier with ~90% revenue concentration in Lam Research and Applied Materials printed a clean Q1 on 2026-05-04 ($256.1M revenue, +15% sequential, upper end of guide) and guided Q2 to $290–310M with EPS turning positive. The market front-ran all of it: +241% YTD and +99% on the quarter into a 52-week high of $78. That leg is now unwinding -11.5% on 2026-06-05 to $62.91, through both the 20-day (~$71) and the 50-day (~$64), with directors selling into the top. This is a post-mania pullback in a name whose re-rating is largely complete; the pre-sell-side narrative window this playbook hunts is already closed. No fresh-entry edge until the structure resets.

Bull Case

• Q1 beat + accelerating guide (2026-05-04): Revenue $256.1M, +15% QoQ, at the upper end of guidance; Q2 guided $290–310M (a further +13–21% sequential) with GAAP and non-GAAP EPS turning positive. The fundamental trajectory is genuinely accelerating.
• Sell-side stepped up post-print: Consensus PT raised ~36% to $76.71; 2026 revenue estimate lifted to $1.20B (from $1.12B) and EPS to $0.60 (from $0.49) across 7 analysts, consensus Strong Buy.
• Gross-margin inflection underway: Q1 GM 12.6% GAAP / 12.8% non-GAAP, with management framing a path higher as utilization normalizes the operating-leverage story that re-rates a low-margin subsystem name into WFE torque.
• Industry WFE backdrop still ACCELERATING: LRCX/AMAT on positive tape, AI-driven leading-edge and HBM demand pulling subsystem orders; ICHR is high-beta (1.88) leverage on that spend.
• Primary trend intact: price still ~77% above the 200-day (~$35.5). The parabola has broken the short-term trend only, not the multi-month uptrend.

Bear Case

• The move is largely behind it: +241% YTD, +99% quarter, tagged $78. PTs already raised, retail momentum pieces out (Quartz "Great Momentum Stock" 2026-05-13, MarketWatch AI-wave piece 2026-06-04) late-stage attention, not an early read.
• Insider distribution into the high: Director Laura Black sold 20,000 shares 2026-06-02; Motley Fool flagged the director trim 2026-06-04. Insiders selling the top is a distribution tell.
• RSI(14) cooled to ~42 from overbought. Momentum, the actual edge, has flipped negative.
• Still GAAP-unprofitable, two-customer business: TTM net income -$50.7M, EPS -1.48; ~90% of revenue in LRCX+AMAT. Any CY2026 WFE guide cut from either is an instant revenue-revision cliff.
• Squeeze fuel spent: short float collapsed to 4.54% (1.55M shares, 1.7-day cover) from ~11% earlier in the year shorts covered into the run, removing a prior upside accelerant.

Setup & Price Structure

• Price ~$62.91 after a -11.5% session on 2026-06-05 (after-hours $63.46). A two-day decline of ~13% from ~$72.45, accelerating to the downside an active momentum unwind.
• Moving averages: 20-day ≈ $71 (price ~11% below), 50-day ≈ $64 (price ~2% below, just lost it), 200-day ≈ $35.5 (price ~77% above). The name is correcting from euphoria back toward trend.
• RSI(14) ≈ 42 no longer overbought, not yet oversold. Mid-range, consistent with an unfinished pullback.
• No clean entry trigger at current price. A momentum book buys strength off a reset (a higher-low above the 50-day plus a reclaim of the 20-day near $71) or a breakout-retest. A knife dropping 11.5% through support on director selling is the opposite setup. The clean entry was the 2026-05-04 gap.
• Key shelves below: the 50-day (~$64), then the May-04 earnings gap / $50–55 breakout zone (old Stifel $55 target area), then the 200-day (~$35.5) on a full failure.

Catalyst Calendar (next 30 days)

• No confirmed hard binary before ~2026-07-07. The next own-catalyst is the Q2 print, est. ~early August 2026 (confirm on IR page) outside the 30-day window.
• SEMICON West 2026 (~mid-July, est.): industry-sentiment read on WFE spend; a soft catalyst that can move the whole semicap complex.
• Peer WFE commentary: any LRCX/AMAT/UCTT conference appearance or pre-announcement is a same-day read-through given the ~90% customer overlap.
• Form 4 flow: further director/officer sales would extend the distribution signal watch EDGAR through the window.

What Would Change Our Mind

• Re-engage on strength: a higher-low that holds the 50-day (~$64) followed by a reclaim of the 20-day (~$71) on expanding volume a breakout-retest that re-establishes the uptrend after the shakeout.
• Confirm the leg is finished: a weekly close decisively below the 50-day on >1.5x average volume, then a loss of the May-04 gap / $50–55 shelf that signals the post-print enthusiasm has fully reset and the name needs months, not days, to repair.
• Fundamental break: Q2 revenue below the $290–310M guide, a gross-margin reversal back under ~12%, or any CY2026 WFE outlook cut from LRCX or AMAT any one ends the re-rating story.

Correlation Notes

• Effectively one WFE bet with UCTT and the LRCX/AMAT complex historical correlation >0.85 with UCTT. Holding ICHR alongside UCTT or LRCX is concentration, not diversification.
• High beta (1.88) amplifies both the semicap tape and broad-market risk-off; a Nasdaq/SOX drawdown lands harder here than on the average semi name.
• ~90% customer concentration (LRCX + AMAT) makes single-customer guidance, rather than sector data alone, the dominant risk vector for the revenue line.